Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer

Published:2022-01 Issue:1 Volume:164 Page:129-135
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Orellana T.J.,Kim H.,Beriwal S.,Bhargava R.,Berger J.,Buckanovich R.J.,Coffman L.G.,Courtney-Brooks M.,Mahdi H.,Olawaiye A.B.,Sukumvanich P.,Taylor S.E.,Smith K.J.,Lesnock J.L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference43 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up;Colombo;Ann. Oncol.,2016

3. Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/carboplatin in high-intermediate and high-risk early stage endometrial cancer;Randall;J. Clin. Oncol.,2019

4. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial;de Boer;Lancet Oncol,2018

5. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study;Keys;Gynecol. Oncol.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients;Practical Radiation Oncology;2024-07

2. Consenso colombiano para el diagnóstico molecular del cáncer de endometrio;Revista Colombiana de Obstetricia y Ginecología;2024-06-17

3. Special Considerations in Classification and Workup of Endometrial Carcinomas;Archives of Pathology & Laboratory Medicine;2023-11-06

4. Budget impact analysis of molecular subtype profiling in endometrial cancer;Gynecologic Oncology;2023-11

5. Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer;Gynecologic Oncology;2023-06